USPTO serial 79299814
TMEXPLORE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Sep 14, 2021
- Examiner
- SPRUILL, DARRYL M
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with TMEXPLORE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $748*
Plus Government fees of $650
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Stanley M. Schurgin
Stanley M. Schurgin Preti Flaherty Beliveau & Pachios LLP60 State StreetSuite 1100Boston, MA 02109Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research, development, technical design and scientific testing services in the field of oncology; research and development of new products for third parties in the pharmaceutical field; industrial analysis and research services in the field of oncology; biomarker analysis services for pharmaceutical research purposes; microbiological testing services for medical and scientific research; testing biomarkers for clinical trials; tests in laboratories namely testing of cancer related biomarkers; laboratory research services concerning pharmaceutical products; development of testing methods namely development of testing specifications and procedures for the characterization of tumors and tumor microenvironment; research, development, technical design, testing, analysis services and consultation services related thereto in the fields of immunology and oncology; Research and development of antibodies, therapeutic products, vaccines, immunotherapy treatments and diagnostic products; research services in the fields of biomarker analysis, immune repertoire analysis, tissue and genome analysis; design and development of software in the field of biology | ACTIVE | — |
| 044 | Medical analysis services relating to the clinical diagnostic and ongoing evaluation, analysis and study of a cancer or tumor microenvironment; medical assistance; health services namely health assessment services; pharmaceutical compound evaluation services; therapeutic services in the field of oncology diagnosis; medical diagnostics, diagnostics in the field of medicine; genetic and/or tissue analysis services for medical purposes; medical testing services for diagnostic or treatment purposes; medical services for the detection, qualification, localization of proteins or cells on a section of biological tissue for the purposes of medical diagnosis | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Aug 21, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Apr 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 4, 2022 | XXSS | GENERIC MADRID TRANSACTION SENT TO IB | — |
| Mar 4, 2022 | XXCR | GENERIC MADRID TRANSACTION CREATED | — |
| Feb 12, 2022 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 14, 2021 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Sep 14, 2021 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 29, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 29, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 9, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 23, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 5, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 4, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 4, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 5, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 18, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Mar 13, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Mar 12, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 26, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 18, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Dec 14, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Dec 11, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |